270 related articles for article (PubMed ID: 8971836)
1. Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain.
Penar PL; Khoshyomn S; Bhushan A; Tritton TR
Neurosurgery; 1997 Jan; 40(1):141-51. PubMed ID: 8971836
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phospholipase C-gamma1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates.
Khoshyomn S; Penar PL; Rossi J; Wells A; Abramson DL; Bhushan A
Neurosurgery; 1999 Mar; 44(3):568-77; discussion 577-8. PubMed ID: 10069594
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines.
Oude Weernink PA; Verheul E; Kerkhof E; van Veelen CW; Rijksen G
Neurosurgery; 1996 Jan; 38(1):108-13; discussion 113-4. PubMed ID: 8747958
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
Klein JM; McCarthy TA
Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
[TBL] [Abstract][Full Text] [Related]
5. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
[TBL] [Abstract][Full Text] [Related]
6. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.
Blair HC; Jordan SE; Peterson TG; Barnes S
J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle.
Yang SG; Saifeddine M; Hollenberg MD
Can J Physiol Pharmacol; 1992 Jan; 70(1):85-93. PubMed ID: 1316219
[TBL] [Abstract][Full Text] [Related]
8. Tri-iodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factor-associated tyrosine kinase activity.
Di Fulvio M; Coleoni AH; Pellizas CG; Masini-Repiso AM
J Endocrinol; 2000 Jul; 166(1):173-82. PubMed ID: 10856896
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
10. Effect of tyrosine kinase inhibition on surfactant protein A gene expression during human lung development.
Klein JM; DeWild LJ; McCarthy TA
Am J Physiol; 1998 Apr; 274(4 Pt 1):L542-51. PubMed ID: 9575872
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M
Leukemia; 1993 Dec; 7(12):2012-8. PubMed ID: 8255101
[TBL] [Abstract][Full Text] [Related]
12. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation.
Peterson G; Barnes S
Prostate; 1993; 22(4):335-45. PubMed ID: 8497428
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro.
Hölting T; Siperstein AE; Clark OH; Duh QY
Eur J Endocrinol; 1995 Feb; 132(2):229-35. PubMed ID: 7858744
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression.
Theodorescu D; Laderoute KR; Calaoagan JM; Guilding KM
Int J Cancer; 1998 Dec; 78(6):775-82. PubMed ID: 9833772
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin.
Klemke RL; Yebra M; Bayna EM; Cheresh DA
J Cell Biol; 1994 Nov; 127(3):859-66. PubMed ID: 7525598
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists.
Laniyonu AA; Saifeddine M; Yang SG; Hollenberg MD
Can J Physiol Pharmacol; 1994 Sep; 72(9):1075-85. PubMed ID: 7842390
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
Mishra S; Mathur R; Hamburger AW
Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
[TBL] [Abstract][Full Text] [Related]
18. Preferential inhibition of glioblastoma cells with wild-type epidermal growth factor receptors by a novel tyrosine kinase inhibitor ethyl-2,5-dihydroxycinnamate.
Han Y; Caday CG; Umezawa K; Nanda A
Oncol Res; 1997; 9(11-12):581-7. PubMed ID: 9563005
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro.
Naraghi S; Khoshyomn S; DeMattia JA; Vane DW
J Pediatr Surg; 2000 Jun; 35(6):884-90. PubMed ID: 10873031
[TBL] [Abstract][Full Text] [Related]
20. Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.
Nagane M; Narita Y; Mishima K; Levitzki A; Burgess AW; Cavenee WK; Huang HJ
J Neurosurg; 2001 Sep; 95(3):472-9. PubMed ID: 11565870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
